Reduced dose intensity of docetaxel plus capecitabine as second-line palliative chemotherapy in patients with metastatic gastric cancer: a phase II study

Autor: Rosati, G. *, Bilancia, D., Germano, D., Dinota, A., Romano, R., Reggiardo, G., Manzione, L.
Zdroj: In Annals of Oncology June 2007 18 Supplement 6:vi128-vi132
Databáze: ScienceDirect